|Bid||143.29 x 800|
|Ask||144.26 x 900|
|Day's Range||139.14 - 148.62|
|52 Week Range||56.54 - 286.19|
|Beta (5Y Monthly)||1.73|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 05, 2021 - May 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||216.83|
LOS ANGELES, CA / ACCESSWIRE / March 4, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.
New York, New York--(Newsfile Corp. - March 4, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of iRhythm Technologies, Inc. (NASDAQ: IRTC) alleging that the Company violated federal securities laws.Class Period: August 4, 2020 and January 28, 2021Lead Plaintiff Deadline: April 2, 2021Learn more about your recoverable losses in IRTC:http://www.kleinstocklaw.com/pslra-1/irhythm-technologies-inc-loss-submission-form?id=13319&from=5The filed complaint alleges that iRhythm Technologies, Inc. made materially false and/or misleading statements ...
NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of iRhythm Technologies, Inc. (NASDAQ: IRTC) between August 4, 2020 and January 28, 2021, inclusive (the “Class Period”). To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=irhythm-technologies-inc&id=2575 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email firstname.lastname@example.org for information on the class action. 如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=irhythm-technologies-inc&id=2575 If you wish to serve as lead plaintiff, you must move the Court before the April 2, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that- iRhythm’s business would suffer as a result of the U.S. Centers for Medicare and Medicaid Services’ (“CMS”) rulemaking; reimbursement rates would in fact plummet; a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in the Company’s business; and as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. Lead plaintiff status is not required to seek compensation. You may retain counsel of your choice. You may remain an absent class member and take no action at this time. Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes. Zhang Investor Law P.C.99 Wall Street, Suite 232New York, New York email@example.com: (800) 991-3756